All News #Library
Others
SPI Pharma & Inimmune to Develop &Commercialize Vaccine Adjuvant
17 Jul 2024 //
PR NEWSWIRE
Inimmune announces First Subject Dosed in First-in-Human Ph 1 Trial of INI-2004
02 Aug 2023 //
PR NEWSWIRE

Market Place
Sourcing Support